In a second KPC clone (KPC2), despite a milder ablation of the targeted protein (Extended Data Fig. 2c), Slc4a4 depletion led to an ~50% reduction in tumor growth and metastatic mesenteric lymph nodes (Extended Data Fig. 2l,m). This evidence concerns the gene SLC4A4 and neoplasm.